From KRAS-G12D to Pan-KRAS Inhibitors: Synthetic Innovation and Drug Design Data

Figshare hosts a 2.5 KB CSV file authored by Xiaoshen Ma, last updated on April 9, 2026. The dataset relates to drug discovery efforts for the KRAS oncology target, specifically covering mutant-specific and pan-KRAS inhibitors. It describes the utilization of synthetic innovations and structure-based drug design in this research area.

Use Cases

• Analyze drug design strategies based on the description of synthetic innovations
• Study inhibitor development pathways based on the transition from mutant-specific to pan-KRAS inhibitors described
• Review structure-based drug design methodologies referenced in the dataset description

Strengths

• File size is precisely 2.5 KB, indicating a compact dataset
• License is explicitly CC-BY-NC-4.0, clarifying reuse terms
• Last update timestamp is provided: 2026-04-09 11:33:54

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Description metadata is limited; actual data quality requires manual inspection after download

Provenance

Source

Xiaoshen Ma via figshare

Collection Method

Likely contains data related to synthetic innovation and structure-based drug design research.

Time Range

Update date is 2026-04 09, but temporal coverage of the data is unknown.

Freshness

Last updated 2026-04-09 11:33:54; freshness should be verified

Geography

Spatial coverage is not specified.